NCI Definition: A hemangioblastoma that arises from the retina. It is typically a sign of von Hippel-Lindau disease. It may also be seen as an isolated entity without systemic involvement. 
There is 1 clinical trial for retinal hemangioblastoma, of which 0 are open and 1 is completed or closed. Of the trial that contains retinal hemangioblastoma as an inclusion criterion, 1 is phase 1/phase 2 (0 open).
VHL is the most frequent gene inclusion criterion for retinal hemangioblastoma clinical trials .
Significant Genes in Retinal Hemangioblastoma
VHL is an inclusion eligibility criterion in 1 clinical trial for retinal hemangioblastoma, of which 0 are open and 1 is closed. Of the trial that contains VHL status and retinal hemangioblastoma as inclusion criteria, 1 is phase 1/phase 2 (0 open) .
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.